Optiscan Imaging Ltd (OIL.AX) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · Australia · ISIN AU000000OIL4

Price
0.16 AUD
Market cap
154.40 m AUD
P/E (2026)
–
P/S (2026)
344.05
Dividend yield
0.00 %
Net margin
-1,556.71 %
Return on equity (ROE)
-36.88 %
Return on assets (ROA)
-31.71 %

Optiscan Imaging Ltd financials

Fiscal year20252026
Revenue3.72 m AUD448,769.00 AUD
Gross profit3.25 m AUD-790,192.00 AUD
Operating income-6.17 m AUD-10.60 m AUD
EBIT-6.60 m AUD-10.60 m AUD
Net income-6.31 m AUD-6.99 m AUD
Diluted EPS – continuing operations-0.01 AUD-0.01 AUD

Full history since 1998, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Optiscan Imaging Ltd

Optiscan Imaging Limited engages in the development, manufacture, and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.